The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive multiplatform biomarker analysis of 313 hepatocellular carcinoma to identify potential therapeutic options.
 
Ghassan K. Abou-Alfa
Consulting or Advisory Role - Aduro Biotech (I); Astellas Pharma; AstraZeneca (I); Celgene; Celsion; cipla; Exelixis; IntegraGen; Jennerex; Lilly/ImClone; MedImmune; Novartis; Pharmacyclics (I); Sanofi (I); Silenseed (I); Vicus Therapeutics
Research Funding - Abbott Laboratories (Inst); Amgen (Inst); Bayer (Inst); Exelixis (Inst); Genentech (Inst); Lilly/ImClone (Inst); Novartis (Inst); Polaris (Inst); Roche (Inst); Vicus Therapeutics (Inst)
Travel, Accommodations, Expenses - Polaris
 
John Thomas Miura
No Relationships to Disclose
 
T. Clark Gamblin
No Relationships to Disclose
 
Joanne Xiu
Employment - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
Research Funding - Caris Life Sciences
 
Sherri Z. Millis
Employment - Caris Life Sciences
 
Zoran Gatalica
Employment - Caris Life Sciences (I)
Leadership - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
 
Sandeep K. Reddy
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
 
Celina Ang
Consulting or Advisory Role - Bayer
 
Nelson S. Yee
No Relationships to Disclose